1. Home/
  2. Compounds/
  3. Nilotinib



SourcesNames Used
CCLE, GDSC1000, FIMMNilotinib
PharmacoGx Nilotinib

External IDs

Smiles: CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5
Pubchem: 644241

Annotated Targets


Cell lines tested with Nilotinib

1260 cell lines have been tested with this compound, using data from 4 dataset(s).
IGROV-1 ovary CCLE, GDSC1000, FIMM, CTRPv25
A549 lung CCLE, GDSC1000, CTRPv25
CAL-51 breast GDSC1000, FIMM, CTRPv24
T47D breast CCLE, GDSC1000, FIMM, CTRPv24
SUIT-2 pancreas CCLE, GDSC1000, CTRPv24
SK-OV-3 ovary CCLE, GDSC1000, FIMM, CTRPv24
OVCAR-8 ovary CCLE, GDSC1000, FIMM, CTRPv24
OVCAR-4 ovary CCLE, GDSC1000, FIMM, CTRPv24
OV-90 ovary CCLE, GDSC1000, FIMM, CTRPv24
OCI-AML5 haematopoietic and lymphoid tissue CCLE, GDSC1000, FIMM, CTRPv24
Download CSV
Download Data as CSV

Top molecular features associated with response to Nilotinib

Feature TypeStandardized
Nominal ANOVA
mRNA CFAP161 GDSC1000 AAC 0.52 1e-55
mRNA PIM1 CTRPv2 AAC 0.52 5e-49
mRNA CISH CTRPv2 AAC 0.49 1e-43
mRNA PRSS57 GDSC1000 AAC 0.5 3e-42
mRNA APOL4 CCLE AAC 0.62 5e-41
mRNA APOL4 GDSC1000 AAC 0.47 2e-40
mRNA OSM GDSC1000 AAC 0.5 9e-40
mRNA CISH GDSC1000 AAC 0.48 3e-38
mRNA KLF1 GDSC1000 AAC 0.42 2e-34
mRNA RHD GDSC1000 AAC 0.39 8e-30
Download CSV